Compounds > caprylates
Page last updated: 2024-09-03

caprylates and homovanillic acid

caprylates has been researched along with homovanillic acid in 4 studies

Compound Research Comparison

Studies
(caprylates)		Trials
(caprylates)		Recent Studies (post-2010)
(caprylates)		Studies
(homovanillic acid)		Trials
(homovanillic acid)		Recent Studies (post-2010) (homovanillic acid)
5,0611002,3396,127312438

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dallaire, L; Grignon, B; Melançon, SB; Potier, M1
Araki, T; Kato, H; Kurosaki, R; Oki, C1
Araki, T; Himeda, T; Kadoguchi, N; Kamiyama, Y; Kato, H; Maegawa, H1
Joniec-Maciejak, I; Maciejak, P; Mirowska-Guzel, D; Płaźnik, A; Sobolewska, A; Szyndler, J; Turzyńska, D; Wawer, A1

Other Studies

4 other study(ies) available for caprylates and homovanillic acid

ArticleYear
[Comparative study of urine and serum organic acids in newborn infants using gas chromatography].
    L'union medicale du Canada, 1974, Volume: 103, Issue:4

    Topics: Acids; Amino Acid Metabolism, Inborn Errors; Benzoates; Blood Chemical Analysis; Caprylates; Chromatography, Gas; Citrates; Female; Glutamates; Hippurates; Homovanillic Acid; Humans; Lactates; Male; Malonates; Mandelic Acids; Palmitic Acids; Phenylacetates; Stearic Acids; Succinates; Tyrosine; Umbilical Cord; Urine; Valerates

1974
Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
    Brain research, 2004, Dec-24, Volume: 1030, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Astrocytes; Caprylates; Cell Communication; Dopamine; Glial Fibrillary Acidic Protein; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Microglia; Movement Disorders; MPTP Poisoning; Neurons; Neuroprotective Agents; S100 Proteins

2004
Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
    Neuropharmacology, 2006, Volume: 50, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain; Brain Chemistry; Caprylates; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Interactions; Homovanillic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Models, Biological; Motor Activity; Neuroprotective Agents; Neurotoxins; Nitric Oxide; Nitric Oxide Synthase; Superoxide Dismutase; Time Factors; Tyrosine 3-Monooxygenase

2006
Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson's disease.
    Pharmacological reports : PR, 2018, Volume: 70, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Caprylates; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Mice; Neuroprotective Agents; Parkinson Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphoenolpyruvate Carboxykinase (GTP)

2018